201 related articles for article (PubMed ID: 11389879)
1. Cytochrome P450 CYP1B1 protein expression: a novel mechanism of anticancer drug resistance.
McFadyen MC; McLeod HL; Jackson FC; Melvin WT; Doehmer J; Murray GI
Biochem Pharmacol; 2001 Jul; 62(2):207-12. PubMed ID: 11389879
[TBL] [Abstract][Full Text] [Related]
2. Docetaxel (Taxotere) is not metabolized by recombinant human CYP1B1 in vitro, but acts as an effector of this isozyme.
Bournique B; Lemarié A
Drug Metab Dispos; 2002 Nov; 30(11):1149-52. PubMed ID: 12386117
[TBL] [Abstract][Full Text] [Related]
3. Use of V79 cells with stably transfected cytochrome P450 cDNAs in studying the metabolism and effects of cytotoxic drugs.
Philip PA; Ali-Sadat S; Doehmer J; Kocarek T; Akhtar A; Lu H; Chan KK
Cancer Chemother Pharmacol; 1999; 43(1):59-67. PubMed ID: 9923542
[TBL] [Abstract][Full Text] [Related]
4. Human CYP1B1 and anticancer agent metabolism: mechanism for tumor-specific drug inactivation?
Rochat B; Morsman JM; Murray GI; Figg WD; McLeod HL
J Pharmacol Exp Ther; 2001 Feb; 296(2):537-41. PubMed ID: 11160641
[TBL] [Abstract][Full Text] [Related]
5. CYP1B1 expression is induced by docetaxel: effect on cell viability and drug resistance.
Martinez VG; O'Connor R; Liang Y; Clynes M
Br J Cancer; 2008 Feb; 98(3):564-70. PubMed ID: 18212750
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 CYP1B1 interacts with 8-methoxypsoralen (8-MOP) and influences psoralen-ultraviolet A (PUVA) sensitivity.
Deeni YY; Ibbotson SH; Woods JA; Wolf CR; Smith G
PLoS One; 2013; 8(9):e75494. PubMed ID: 24086543
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity of cyclophosphamide, paclitaxel, and docetaxel for tumor cell lines in vitro: effects of concentration, time and cytochrome P450-catalyzed metabolism.
Gut I; Danielová V; Holubová J; Soucek P; Klucková H
Arch Toxicol; 2000 Oct; 74(8):437-46. PubMed ID: 11097380
[TBL] [Abstract][Full Text] [Related]
8. Design and Synthesis of New α-Naphthoflavones as Cytochrome P450 (CYP) 1B1 Inhibitors To Overcome Docetaxel-Resistance Associated with CYP1B1 Overexpression.
Cui J; Meng Q; Zhang X; Cui Q; Zhou W; Li S
J Med Chem; 2015 Apr; 58(8):3534-47. PubMed ID: 25799264
[TBL] [Abstract][Full Text] [Related]
9. Expression of paclitaxel-inactivating CYP3A activity in human colorectal cancer: implications for drug therapy.
Martínez C; García-Martín E; Pizarro RM; García-Gamito FJ; Agúndez JA
Br J Cancer; 2002 Sep; 87(6):681-6. PubMed ID: 12237780
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450 CYP1B1 activity in renal cell carcinoma.
McFadyen MC; Melvin WT; Murray GI
Br J Cancer; 2004 Aug; 91(5):966-71. PubMed ID: 15280921
[TBL] [Abstract][Full Text] [Related]
11. Regioselective metabolism of taxoids by human CYP3A4 and 2C8: structure-activity relationship.
Cresteil T; Monsarrat B; Dubois J; Sonnier M; Alvinerie P; Gueritte F
Drug Metab Dispos; 2002 Apr; 30(4):438-45. PubMed ID: 11901098
[TBL] [Abstract][Full Text] [Related]
12. Development of a human lymphoblastoid cell line constitutively expressing human CYP1B1 cDNA: substrate specificity with model substrates and promutagens.
Crespi CL; Penman BW; Steimel DT; Smith T; Yang CS; Sutter TR
Mutagenesis; 1997 Mar; 12(2):83-9. PubMed ID: 9106248
[TBL] [Abstract][Full Text] [Related]
13. In situ hybridization and immunohistochemical analysis of cytochrome P450 1B1 expression in human normal tissues.
Muskhelishvili L; Thompson PA; Kusewitt DF; Wang C; Kadlubar FF
J Histochem Cytochem; 2001 Feb; 49(2):229-36. PubMed ID: 11156691
[TBL] [Abstract][Full Text] [Related]
14. Acquired resistance to the anticancer drug paclitaxel is associated with induction of cytochrome P450 2C8.
García-Martín E; Pizarro RM; Martínez C; Gutierrez-Martín Y; Pérez G; Jover R; Agúndez JA
Pharmacogenomics; 2006 Jun; 7(4):575-85. PubMed ID: 16753005
[TBL] [Abstract][Full Text] [Related]
15. Expression of cytochrome P450 (CYP) enzymes in human nonpigmented ciliary epithelial cells: induction of CYP1B1 expression by TCDD.
Volotinen M; Mäenpää J; Kankuri E; Oksala O; Pelkonen O; Nakajima M; Yokoi T; Hakkola J
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3099-105. PubMed ID: 19324859
[TBL] [Abstract][Full Text] [Related]
16. CYP1B1 enhances the resistance of epithelial ovarian cancer cells to paclitaxel in vivo and in vitro.
Zhu Z; Mu Y; Qi C; Wang J; Xi G; Guo J; Mi R; Zhao F
Int J Mol Med; 2015 Feb; 35(2):340-8. PubMed ID: 25516145
[TBL] [Abstract][Full Text] [Related]
17. Chemical toxicity testing in vitro using cytochrome P450-expressing cell lines, such as human CYP1B1.
Landsiedel R; Fabian E; Tralau T; Luch A
Nat Protoc; 2011 May; 6(5):677-87. PubMed ID: 21527924
[TBL] [Abstract][Full Text] [Related]
18. Loss of miR-200c up-regulates CYP1B1 and confers docetaxel resistance in renal cell carcinoma.
Chang I; Mitsui Y; Fukuhara S; Gill A; Wong DK; Yamamura S; Shahryari V; Tabatabai ZL; Dahiya R; Shin DM; Tanaka Y
Oncotarget; 2015 Apr; 6(10):7774-87. PubMed ID: 25860934
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer.
McFadyen MC; Cruickshank ME; Miller ID; McLeod HL; Melvin WT; Haites NE; Parkin D; Murray GI
Br J Cancer; 2001 Jul; 85(2):242-6. PubMed ID: 11461084
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome 450 1B1 (CYP1B1) polymorphisms associated with response to docetaxel in Castration-Resistant Prostate Cancer (CRPC) patients.
Pastina I; Giovannetti E; Chioni A; Sissung TM; Crea F; Orlandini C; Price DK; Cianci C; Figg WD; Ricci S; Danesi R
BMC Cancer; 2010 Sep; 10():511. PubMed ID: 20875115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
